Abstract
Objective:
To review published data on vascular disease- and diabetes-related outcomes related to adiposity and metabolic risk factors.
Design:
Community cohort study with cross-sectional and prospective data.
Subjects:
Middle-aged Caucasian adults in a suburban environment.
Measurements:
Traditional risk factors for cardiovascular disease and the type 2 diabetes mellitus, as well as measures of insulin resistance, left ventricular hypertrophy and vascular calcification.
Results:
The cardiometabolic risk factors cluster in the population and a common core that includes adiposity (both waist and body mass index), abnormal lipids (both HDL cholesterol and triglycerides), and abnormal glucose and insulin metabolism was found to be present in Framingham participants. Increased insulin resistance was also found to be associated with coronary artery calcification and left ventricular hypertrophy in women. Analyses of the metabolic syndrome risk factors showed that a greater burden of risk factors was associated with greater risk of both cardiovascular disease and diabetes mellitus. An equation to estimate risk of developing type 2 diabetes mellitus has been developed from the Framingham experience, and the risk factors included in the metabolic syndrome are key components, including increased waist girth, elevated blood pressure, low HDL cholesterol, high triglycerides and impaired fasting glucose.
Conclusion:
Cardiometabolic factors and insulin resistance are important contributors to the development of type 2 diabetes mellitus, subclinical cardiovascular disease and clinical cardiovascular disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Meigs JB, Nathan DM, Wilson PW, Cupples LA, Singer DE . Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study. Ann Intern Med 1998; 128: 524–533.
Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB . Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999; 159: 1104–1109.
Meigs JB, D'Agostino RB, Wilson PWF, Cupples LA, Nathan DM, Singer DE . Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997; 46: 1594–1600.
Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003; 107: 448–454.
Meigs JB, Larson MG, D'Agostino RB, Levy D, Clouse ME, Nathan DM et al. Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham Offspring Study. Diabetes Care 2002; 25: 1313–1319.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
Ford ES . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769–1778.
McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385–390.
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.
Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066–3072.
Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino Sr RB . Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007; 167: 1068–1074.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wilson, P., Meigs, J. Cardiometabolic risk: a Framingham perspective. Int J Obes 32 (Suppl 2), S17–S20 (2008). https://doi.org/10.1038/ijo.2008.30
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2008.30
Keywords
This article is cited by
-
Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort
BMC Public Health (2023)
-
Changes in body composition and metabolic disease risk
European Journal of Clinical Nutrition (2019)
-
Association of longitudinal risk profile trajectory clusters with adipose tissue depots measured by magnetic resonance imaging
Scientific Reports (2019)
-
Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Cardiometabolic Risk Factors: A Study Among Bhil Tribal Population from Two Environmental Settings
Biochemical Genetics (2018)
-
Stress and cardiovascular disease risk in female law enforcement officers
International Archives of Occupational and Environmental Health (2011)